OmniAb (OABI) EBT (2021 - 2026)
OmniAb (OABI) reported EBT of -$7.3 million for Q1 2026, up 60.31% year-over-year from -$4.5 million in Q1 2025, and up 50.05% on a QoQ basis from -$14.5 million in Q4 2025.
OmniAb (OABI) has 6 years of EBT data on file, last reported at -$7.3 million in Q1 2026.
- Quarterly EBT rose 60.31% year-over-year to -$7.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$55.3 million (up 18.91% YoY) and the FY2025 annual result came in at -$66.3 million, up 7.17% from the prior year.
- EBT advanced to -$7.3 million in Q1 2026 per OABI's latest filing, from -$14.5 million in the prior quarter.
- Across five years, EBT topped out at $9.6 million in Q4 2022 and bottomed at -$21.6 million in Q1 2024.
- The 5-year median for EBT is -$15.5 million (2024), against an average of -$13.8 million.
- Peak annual rise in EBT reached 127.2% in 2022, while the deepest fall reached 575002.97% in 2022.
- Tracing OABI's EBT over 5 years: stood at $9.6 million in 2022, then slumped by 307.82% to -$20.0 million in 2023, then increased by 23.99% to -$15.2 million in 2024, then grew by 4.45% to -$14.5 million in 2025, then surged by 50.05% to -$7.3 million in 2026.
- Per Business Quant, the three latest OABI EBT figures stand at -$7.3 million (Q1 2026), -$14.5 million (Q4 2025), and -$17.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.31 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.18 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 831.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 221.65 Mn |
| 10 | OmniAb | 334.72 Mn | 291.75 Mn | 14.41 Mn | -7.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.27 Mn |
| Dec 31, 2025 | -14.55 Mn |
| Sep 30, 2025 | -17.69 Mn |
| Jun 30, 2025 | -15.76 Mn |
| Mar 31, 2025 | -18.31 Mn |
| Dec 31, 2024 | -15.22 Mn |
| Sep 30, 2024 | -19.08 Mn |
| Jun 30, 2024 | -15.53 Mn |
| Mar 31, 2024 | -21.58 Mn |
| Dec 31, 2023 | -20.03 Mn |
| Sep 30, 2023 | -19.04 Mn |
| Jun 30, 2023 | -18.16 Mn |
| Mar 31, 2023 | -7.13 Mn |
| Dec 31, 2022 | 9.64 Mn |
| Sep 30, 2022 | -14.91 Mn |
| Jun 30, 2022 | -12.57 Mn |
| Mar 31, 2022 | -8.22 Mn |
| Dec 31, 2021 | -35.43 Mn |
| Sep 30, 2021 | -170,579.00 |
| Jun 30, 2021 | -2,185.00 |
| Mar 31, 2021 | -7,786.00 |